Systemic mastocytosis: A rare cause of noncirrhotic portal hypertension simulating autoimmune cholangitis - Report of four cases

American Journal of Gastroenterology

Volumn 93, Issue 1, 1998, Pages 106-108

  Kyriakou, D ^a   Kouroumalis, E ^a   Konsolas, J ^a   Oekonomaki, H ^a   Tzardi, M ^a   Kanavaros, P ^a   Manoussos, O ^a   Eliopoulos, G D ^a  

^a UNIVERSITY OF CRETE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CYTARABINE; HYDROXYUREA; RECOMBINANT ALPHA2B INTERFERON;

ACUTE NONLYMPHOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; ASCITES; AUTOIMMUNE DISEASE; BACKACHE; CANCER RADIOTHERAPY; CASE REPORT; CHOLANGITIS; DIAGNOSTIC ERROR; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER BIOPSY; MALE; MAST CELL; PATHOLOGIC FRACTURE; PORTAL HYPERTENSION; PRIORITY JOURNAL; SYSTEMIC MASTOCYTOSIS; VERTEBRA FRACTURE;

AGED; AUTOIMMUNE DISEASES; BIOPSY; BONE MARROW; CHOLANGITIS; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION, PORTAL; LEUKEMIA, MAST-CELL; LIVER; LIVER CIRRHOSIS; MALE; MAST CELLS; MASTOCYTOSIS; MIDDLE AGED; TIME FACTORS;

EID: 0032409975     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(97)00042-7     Document Type: Article

References (21)

1. Austen KF. Systemic mastocytosis. N Engl J Med. 326:1992;639-640.
2. Webb T, Li C, Yal L. Systemic mast cell disease. A study of 26 cases. Cancer. 49:1982;927-938.
3. Mican JM, Di Bisceglie AM, Fong TL, et al. Hepatic involvement in mastocytosis: Clinicopathologic correlations in 41 cases. Hepatology. 22:1995;1163-1170.
4. Travis WD, Li CY, Bergstralh E, et al. Systemic mast cell disease. Analysis of 58 cases and literature review. Medicine. 67:1988;345-368.
5. Roberts LJ. Recurrent syncope due to systemic mastocytosis. Hypertention. 6:1984;285-294.
6. 2 production. Neth J Med. 26:1983;18-20.
7. Turk J, Oats JA, Roberts LJ. Intervention with epinephrine in hypotension associated with mastocytosis. J Allergy Clin Immunol. 71:1983;189-192.
8. Cherner JA, Jensen RT, Dubois F, et al. Gastrointestinal dysfunction in systemic mastocytosis. A prospective study. Gastroenterology. 95:1988;657-667.
9. Frijns CJ, Troost J. Generalized mastocytosis and neurological complications in a 71-year-old patient. Clin Neurol Neurosurg. 94:1992;257-260.
10. Schwartz LB, Austen K. Structure and function of the chemical mediators of mast cells. Progr Allergy. 34:1984;271-321.
11. Goodman ZD, McNally PR, Davis DR, et al. Autoimmune cholangitis: A variant of primary billiary cirrhosis. Clinicopathologic and serologic correlations in 200 cases. Dig Dis Sci. 40:1995;1232-1242.
12. Schwartz LB, Metcalfe DD, Miller JS, et al. Tryptase levels as an indicator of mast cell activation. N Engl J Med. 316:1987;1622-1626.
13. Tourneau A, Gaulard P, MF D'Agay, et al. Primary thrombocythaemia associated with systemic mastocytosis: A report of five cases. Br J Haematol. 79:1991;84-89.
14. Hutchinson RM. Mastocytosis and co-existent non-Hodgkin's lymphoma and myeloproliferative disorders. Leuk Lymphoma. 7:1992;29-36.
15. Dash S, Rao NR, Deodhar SD, et al. Malignant mastocytosis and myelodysplastic syndrome. Br J Haematol. 79:1991;530-531.
16. Petit A, Pulik M, Gaulier A, et al. Systemic mastocytosis associated with chronic myelomonocytic leukemia: Clinical features and response to interferon alpha therapy. J Am Acad Dermatol. 32:1995;850-853.
17. Travis W, Li CY, Hoagland JC. Mast cell leukemia: Report of a case and review of the literature. Mayo Clin Proc. 61:1986;957-966.
18. Pal B. Systemic mastocytosis and Sjögren's syndrome. Ann Rheum Dis. 51:1992;277-278.
19. 2 receptor antagonists. Dermatology. 184:1992;149-152.
20. Kluin-Nelemans H, Jansen J, Breukelman H, et al. Response to interferon alpha-2b in a patient with systemic mastocytosis. N Engl J Med. 326:1992;619-623.
21. Janjan NA, Conway P, Lundberg J, et al. Radiation therapy in a case of systemic mastocytosis: Evaluation of histamine levels and mucosal effects. Am J Clin Oncol. 15:1992;337-339.